4//SEC Filing
Lawrence Cameron William 4
Accession 0001209191-11-012469
CIK 0000949858other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:04 PM ET
Size
9.2 KB
Accession
0001209191-11-012469
Insider Transaction Report
Form 4
Lawrence Cameron William
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2011-02-22$3.00/sh+1,400$4,200→ 4,450 total(indirect: RRSP) - Exercise/Conversion
Stock Option (right to buy)
2011-02-22−1,875→ 3,750 totalExercise: $3.00Exp: 2015-12-31→ Common (1,875 underlying) - Exercise/Conversion
Common Stock
2011-02-22$3.00/sh+475$1,425→ 950 total(indirect: By Spouse)
Footnotes (1)
- [F1]1,875 shares are exercisable on each of December 31, 2009, 2010, 2011 and 2012.
Documents
Issuer
ONCOGENEX PHARMACEUTICALS, INC.
CIK 0000949858
Entity typeother
Related Parties
1- filerCIK 0001486333
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:04 PM ET
- Size
- 9.2 KB